This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Beresford, M W Articles by Davidson, J E Search for Related Content PubMed PubMed Citation Articles by Beresford, M W Articles by Davidson, J E Social Bookmarking                   What's this?

Cardio-pulmonary involvement in juvenile systemic lupus erythematosus

Department of Rheumatology, Royal Liverpool Children’s NHS Trust, UK, m_beresford{at}yahoo.com

A G Cleary

Department of Rheumatology, Royal Liverpool Children’s NHS Trust, UK

J A Sills

Department of Rheumatology, Royal Liverpool Children’s NHS Trust, UK

J Couriel

Department of Rheumatology, Royal Liverpool Children’s NHS Trust, UK

J E Davidson

Department of Rheumatology, Royal Liverpool Children’s NHS Trust, UK

Cardio-pulmonary manifestations of systemic lupus erythematosus (SLE) are well recognized in adults. We report the occurrence of clinically significant cardio-pulmonary disease in a cohort of predominantly Caucasian children with SLE. All children with SLE attending the Royal Liverpool Children’s NHS Trust between 1995 and 2003 were reviewed. Of 29 children with SLE, 27 (93%) were Caucasian. Nine (31%) had cardio-respiratory complications: cardiac only (n = 1); respiratory only (n = 4); both cardiac and respiratory manifestations (n = 4). Median (range) duration of follow-up of affected children: four years (six months to 11 years). Six out of eight (75%) presented with respiratory complications before SLE was diagnosed. Three children had pericardial effusions, one requiring pericardiocentesis for tamponade. One had cardiac conduction defects and another significant pulmonary hypertension. Respiratory complications comprised: interstitial lung disease (n = 4), with two showing evidence of pulmonary fibrosis; pleural effusions (n = 2), pulmonary haemorrhage (n = 1) and lupus pneumonitis (n = 1). Disease course was complicated by CMV infection in one child. Lung biopsy was performed in five cases. Seven were treated with cyclophosphamide with significant improvement in symptoms/lung function. Of this predominantly Caucasian paediatric cohort with SLE, 31% had significant cardio-pulmonary involvement. All children with SLE should have regular monitoring of their cardio-respiratory status.

Key Words: cardiac complications • juvenile systemic lupus erythematosus • pulmonary complications

Lupus, Vol. 14, No. 2, 152-158 (2005)
DOI: 10.1191/0961203305lu2073oa


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A.M. Bertoli, L.M. Vila, M. Apte, B.J. Fessler, H.M. Bastian, J.D. Reveille, and G.S. Alarcon Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage Lupus, June 1, 2007; 16(6): 410 - 417. [Abstract] [PDF]